Christchurch-based Ossis is planning to become the first company to widely sell 3D printed orthopaedic implants in the lucrative US market.
Ossis, which designs and markets patient-specific pelvic implants, will next month make an application to the United States Food and Drug Administration
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
